Global Market Study on Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics

Aug 2016| PMR017A| Persistence Market Research

Report Highlights

This Persistence Market Research (PMR) report examines the ‘Global ADHD Therapeutics Market for the period 2015-2024. The primary objective of the report is to offer updates and information related to opportunities in the Global ADHD Therapeutics Market.

ADHD is a neurobehavioral disorder among children with symptoms of hyperactivity, inattention, and impulsivity. ADHD is a sustained pattern of inattention and/or impulsivity/hyperactivity, which hampers proper functioning of a child’s brain and development. ADHD begins during childhood, and thus is termed neurodevelopmental disorder even if it is undiagnosed until adulthood. When the degree of inattention and hyperactivity in a child is inconsistent with the child’s current developmental level, the child is classified as an ADHD patient.

Rising in the prevalence of ADHD disorder, availability of multiple treatment options and ADHD drugs specific to age groups, is expected to bolster growth of the ADHD therapeutics market in the near future. Also, increasing awareness regarding ADHD, shift from ICD-10 to DSM-IV and product innovation is expected to drive growth of ADHD therapeutics market during the forecast period.

The ADHD Therapeutics Market segmented as follows:

ADHD Therapeutics Market, by drug type
ADHD Therapeutics Market, by age group
ADHD Therapeutics Market, by distribution channel
ADHD Therapeutics Market, by region
This report covers the global ADHD therapeutics market performance in terms of revenue contribution from various segments. This section also includes PMR analysis of key trends, drivers, restraints and opportunities, which are influencing growth of the global ADHD therapeutics market. Impact analysis of key growth drivers and restraints are included in this report to better equip clients with crystal clear decision-making insights.

The ADHD therapeutics market report begins with an overview of the ADHD and why are the patients worldwide adopting the medication. This section also underlines factors influencing growth of the ADHD therapeutics market along with detailing of the key trends, drivers, restraints, opportunity and regulations. Impact analysis of key regional growth drivers and restraints based on the weighted average model along with key region-specific trends is included in report to better equip clients with information and hidden insights. At the end of the report, PMR has provided key strategic recommendation for both existing and new players in the market to emerge sustainably profitable.

The global ADHD therapeutics market is segmented on the basis of drug type into stimulants (Amphetamine, Methylphenidate, Dextroamphetamine, Dexmethylphenidate, and Lisdexamfetamine Dimesylate) and non-stimulants (Atomoxetine, Bupropion, Guanfacine and Clonidine). Based on age group, the market has been segmented into pediatric and adolescent and adults. Based on distribution channel, the market has been segmented into specialty clinics, hospital pharmacies, retail pharmacies and e-Commerce. A detailed analysis has been provided for every segment and sub-segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market attractive index, and BPS analysis. In terms of drugs type, stimulants are expected to emerge as the drugs of choice, both among physicians and patients worldwide. Amphetamine is also expected to gain popularity over the forecast period.

The next section of the report highlights the growth trends of the global ADHD therapeutics market by region. It provides a market outlook for 2015–2024 and sets the forecast within the context of the ADHD therapeutics market. The study discusses key regional trends contributing to growth of the ADHD therapeutics market worldwide, as well as analysis of the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Europe, Asia Pacific and MEA. North America region is expected to emerge dominant and remain the most attractive market over the forecast period.

The above sections – by drug type, by age group, by distribution channel and by region – evaluate the present scenario and growth prospects of the ADHD therapeutics market for the period 2015 –2024. We have considered 2015 as the base year and provided data for the forecast period.

Detailed company profiles include company-specific long-term and short-term strategies, key offerings and recent developments in the ADHD therapeutics market. Key competitors covered in terms of manufacturers include Eli Lilly and Company, Novartis AG, Shire PLC, Pfizer, Inc., GlaxoSmithKline PLC, Mallinckrodt Pharmaceuticals, Hisamitsu Pharmaceutical Co., Inc., Impax Laboratories, Inc., Johnson & Johnson, UCB S.A., and Purdue Parma L.P.

In the final section of the report, ADHD Therapeutics ‘Strategic Recommendation’ is included to provide insights for companies to strengthen footprint and position themselves in the global ADHD therapeutics market.

The global ADHD therapeutics market is segmented as follows:

By Drug Type

Stimulants
Amphetamine
Methylphenidate
Dextroamphetamine
Dexmethylphenidate
Lisdexamfetamine
Dimesylate
Non-stimulants
Atomoxetine
Bupropion
Guanfacine
Clonidine
By Age Group

Pediatric and Adolescent
Adults
By Distribution Channel

Specialty Clinics
Hospital Pharmacies
Retail Pharmacies
e-Commerce
By Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

  • Table 1 : North America ADHD Therapeutics Market Volume (Unit Mn) Analysis and Forecast By Drug Type, 2015�2024
  • Table 2 : Latin America ADHD Therapeutics Market Volume (Unit Mn) Analysis and Forecast By Drug Type, 2015�2024
  • Table 3 : Europe ADHD Therapeutics Market Volume (Unit Mn) Analysis and Forecast By Drug Type, 2015�2024
  • Table 4 : APAC ADHD Therapeutics Market Volume (Unit Mn) Analysis and Forecast By Drug Type, 2015�2024
  • Table 5 : MEA ADHD Therapeutics Market Volume (Unit Mn) Analysis and Forecast By Drug Type, 2015�2024
  • Table 6 : Global ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015�2024
  • Table 7 : Global ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Age Group, 2015�2024
  • Table 8 : Global ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015�2024
  • Table 9 : Global ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Region, 2015�2024
  • Table 10 : North America ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Country, 2015�2024
  • Table 11 : North America ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015�2024
  • Table 12 : North America ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Age Group, 2015�2024
  • Table 13 : North America ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015�2024
  • Table 14 : Latin America ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Country, 2015�2024
  • Table 15 : Latin America ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015�2024
  • Table 16 : Latin America ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Age Group, 2015�2024
  • Table 17 : Latin America ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015�2024
  • Table 18 : Europe ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Country, 2015�2024
  • Table 19 : Europe ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015�2024
  • Table 20 : Europe ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Age Group, 2015�2024
  • Table 21 : Europe ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015�2024
  • Table 22 : APAC ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Country, 2015�2024
  • Table 23 : APAC ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015�2024
  • Table 24 : APAC ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Age Group, 2015�2024
  • Table 25 : APAC ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015�2024
  • Table 26 : MEA ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Country, 2015�2024
  • Table 27 : MEA ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015�2024
  • Table 28 : MEA ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Age Group, 2015�2024
  • Table 29 : MEA ADHD Therapeutics Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015�2024
  • Figure 1 : Global ADHD Therapeutics Market - Scenario Forecast, 2015-2024 (US$ Mn)
  • Figure 2 : Global ADHD Therapeutics Market, Stimulants Price Difference (US$) By Region, 2015
  • Figure 3 : Global ADHD Therapeutics Market, Stimulants Price Difference (US$) By Region, 2024
  • Figure 4 : Global ADHD Therapeutics Market, Non-stimulants Price Difference (US$) By Region, 2015
  • Figure 5 : Global ADHD Therapeutics Market, Non-stimulants Price Difference (US$) By Region, 2024
  • Figure 6 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
  • Figure 7 : Global ADHD Therapeutics Market Absolute $ Opportunity, 2016-2024
  • Figure 8 : Global ADHD Therapeutics Market Share Analysis (%) By Drug Type, 2016 & 2024
  • Figure 9 : Global ADHD Therapeutics Y-o-Y growth (%) By Drug Type, 2016-2024
  • Figure 10 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%) By Stimulants Drug type Segment, 2015-2024
  • Figure 11 : Global ADHD Therapeutics Market Absolute $ Opportunity By Stimulants Drug Type Segment, 2016-2024
  • Figure 12 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%) By Non-stimulants Drug type Segment, 2015-2024
  • Figure 13 : Global ADHD Therapeutics Market Absolute $ Opportunity By Non-stimulants Drug Type, 2016-2024
  • Figure 14 : Global ADHD Therapeutics Market Attractiveness Analysis By Drug Type, 2016-2024
  • Figure 15 : Global ADHD Therapeutics Market Share Analysis (%) By Age Group, 2016 & 2024
  • Figure 16 : Global ADHD Therapeutics Y-o-Y growth (%) By Age Group, 2016-2024
  • Figure 17 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%) By Pediatric and Adolescent Age Group Segment, 2015-2024
  • Figure 18 : Global ADHD Therapeutics Market Absolute $ Opportunity By Pediatric and Adolescent Age Group Segment, 2016-2024
  • Figure 19 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%) By Adults Age Group Segment, 2015-2024
  • Figure 20 : Global ADHD Therapeutics Market Absolute $ Opportunity By Adults Age Group Segment, 2016-2024
  • Figure 21 : Global ADHD Therapeutics Market Attractiveness Analysis By Age Group, 2016-2024
  • Figure 22 : Global ADHD Therapeutics Market Share Analysis (%) By Distribution Channel, 2016 & 2024
  • Figure 23 : Global ADHD Therapeutics Y-o-Y growth (%) By Distribution Channel, 2016-2024
  • Figure 24 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%) By Specialty Clinics Distribution Channel Segment, 2015-2024
  • Figure 25 : Global ADHD Therapeutics Market Absolute $ Opportunity By Specialty Clinics Distribution Channel Segment, 2016-2024
  • Figure 26 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%) By Hospital Pharmacies Distribution Channel Segment, 2015-2024
  • Figure 27 : Global ADHD Therapeutics Market Absolute $ Opportunity By Hospital Pharmacies Distribution Channel Segment, 2016-2024
  • Figure 28 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%) By Retail Pharmacies Distribution Channel Segment, 2015-2024
  • Figure 29 : Global ADHD Therapeutics Market Absolute $ Opportunity By Retail Pharmacies Distribution Channel Segment, 2016-2024
  • Figure 30 : Global ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%) By e-Commerce Distribution Channel Segment, 2015-2024
  • Figure 31 : Global ADHD Therapeutics Market Absolute $ Opportunity By e-Commerce Distribution Channel Segment, 2016-2024
  • Figure 32 : Global ADHD Therapeutics Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 33 : Global ADHD Therapeutics Market Share Analysis (%) By Region, 2016 & 2024
  • Figure 34 : Global ADHD Therapeutics Y-o-Y growth (%) By Region, 2016-2024
  • Figure 35 : North America ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
  • Figure 36 : North America ADHD Therapeutics Market Absolute $ Opportunity, 2016-2024
  • Figure 37 : Latin America ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
  • Figure 38 : Latin America ADHD Therapeutics Market Absolute $ Opportunity, 2016-2024
  • Figure 39 : Europe ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
  • Figure 40 : Europe ADHD Therapeutics Market Absolute $ Opportunity, 2016-2024
  • Figure 41 : APAC ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
  • Figure 42 : APAC ADHD Therapeutics Market Absolute $ Opportunity, 2016-2024
  • Figure 43 : MEA ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
  • Figure 44 : MEA ADHD Therapeutics Market Absolute $ Opportunity, 2016-2024
  • Figure 45 : Global ADHD Therapeutics Market Attractiveness Analysis By Region, 2016-2024
  • Figure 46 : North America ADHD Therapeutics Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 47 : North America ADHD Therapeutics Y-o-Y growth (%) By Country, 2016-2024
  • Figure 48 : U.S. ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
  • Figure 49 : U.S. ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 50 : Canada ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
  • Figure 51 : Canada ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn) 2016-2024
  • Figure 52 : North America ADHD Therapeutics Market Attractiveness Analysis By Country, 2016-2024
  • Figure 53 : North America ADHD Therapeutics Market Attractiveness Analysis By Drug type, 2016-2024
  • Figure 54 : North America ADHD Therapeutics Market Attractiveness Analysis By Age Group, 2016-2024
  • Figure 55 : North America ADHD Therapeutics Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 56 : Latin America ADHD Therapeutics Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 57 : Latin America ADHD Therapeutics Y-o-Y growth (%) By Country, 2016-2024
  • Figure 58 : Brazil ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
  • Figure 59 : Brazil ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 60 : Mexico ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
  • Figure 61 : Mexico ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 62 : Rest of Latin America ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
  • Figure 63 : Rest of Latin America ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 64 : Latin America ADHD Therapeutics Market Attractiveness Analysis By Country, 2016-2024
  • Figure 65 : Latin America ADHD Therapeutics Market Attractiveness Analysis By Drug type, 2016-2024
  • Figure 66 : Latin America ADHD Therapeutics Market Attractiveness Analysis By Age Group, 2016-2024
  • Figure 67 : Latin America ADHD Therapeutics Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 68 : Europe ADHD Therapeutics Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 69 : Europe ADHD Therapeutics Y-o-Y growth (%) By Country, 2016-2024
  • Figure 70 : Germany ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015�2024
  • Figure 71 : Germany ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 72 : France ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015�2024
  • Figure 73 : France ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 74 : Russia ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015�2024
  • Figure 75 : Russia ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 76 : Italy ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015�2024
  • Figure 77 : Italy ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 78 : Spain ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015�2024
  • Figure 79 : Spain ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 80 : The U.K. ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015�2024
  • Figure 81 : The U.K. ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 82 : Rest of Europe ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015�2024
  • Figure 83 : Rest of Europe ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 84 : Europe ADHD Therapeutics Market Attractiveness Analysis By Country, 2016-2024
  • Figure 85 : Europe ADHD Therapeutics Market Attractiveness Analysis By Drug type, 2016-2024
  • Figure 86 : Europe ADHD Therapeutics Market Attractiveness Analysis By Age Group, 2016-2024
  • Figure 87 : Europe ADHD Therapeutics Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 88 : APAC ADHD Therapeutics Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 89 : APAC ADHD Therapeutics Y-o-Y growth (%) By Country, 2016-2024
  • Figure 90 : China ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015�2024
  • Figure 91 : China ADHD Therapeutics Market Absolute $ Opportunity (US$), 2016-2024
  • Figure 92 : India ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015�2024
  • Figure 93 : India ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 94 : Japan ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015�2024
  • Figure 95 : Japan ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 96 : Australia & New Zealand ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015�2024
  • Figure 97 : Australia & New Zealand ADHD Therapeutics Market Absolute $ Opportunity, 2016-2024
  • Figure 98 : Rest of APAC ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015�2024
  • Figure 99 : Rest of APAC ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 100 : APAC ADHD Therapeutics Market Attractiveness Analysis By Country, 2016-2024
  • Figure 101 : APAC ADHD Therapeutics Market Attractiveness Analysis By Drug type, 2016-2024
  • Figure 102 : APAC ADHD Therapeutics Market Attractiveness Analysis By Age Group, 2016-2024
  • Figure 103 : APAC ADHD Therapeutics Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 104 : MEA ADHD Therapeutics Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 105 : MEA ADHD Therapeutics Y-o-Y growth (%) By Country, 2016-2024
  • Figure 106 : GCC Countries ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015�2024
  • Figure 107 : GCC Countries ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 108 : South Africa ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015�2024
  • Figure 109 : South Africa ADHD Therapeutics Market Absolute $ Opportunity (US$ Mn) 2016-2024
  • Figure 110 : Rest of MEA ADHD Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015�2024
  • Figure 111 : Rest of MEA ADHD Therapeutics Market Absolute $ Opportunity (US$), 2016-2024
  • Figure 112 : MEA ADHD Therapeutics Market Attractiveness Analysis By Country, 2016-2024
  • Figure 113 : MEA ADHD Therapeutics Market Attractiveness Analysis By Drug type, 2016-2024
  • Figure 114 : MEA ADHD Therapeutics Market Attractiveness Analysis By Age Group, 2016-2024
  • Figure 115 : MEA ADHD Therapeutics Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 116 : Global ADHD Therapeutics Company Market Share Analysis, 2015

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report